Group (n) | Control (13) | Hyperlipidemia | |
---|---|---|---|
Untreatment (4) | With treatment (4) | ||
Age | 8.0 (2.8-9.3) | 9.5 (6.0-11.5) | 12.5 (12.-15.0) |
Body condition score | 3.0 (3.0-4.0) | 3.5 (2.3-4.8) | 3.0 (3.0-4.0) |
Body weight (kg) | 5.6 (4.3-14.5) | 7.7 (3.0-21.3) | 8.9 (5.6-26.9) |
Total choresterol (mg/dL) | 240 (170–351) | 241 (231–358) | 367 (347–390) |
Triglycerid (mg/dL) | 48 (28–163) | 252 (196–311)* | 81 (61–88) |
Total protein (g/dL) | 6.8 (6.4-7.4) | 7.5 (6.7-8.0) | 7.3 (7.1-7.7) |
Albmin (g/dL) | 3.3 (3.0-3.4) | 3.4 (3.0-3.8) | 3.3 (3.0-3.6) |
Albumin/globulin ratio | 0.88 (0.79-0.97) | 0.83 (0.80-0.89) | 0.78 (0.76-0.88) |
Total bilirubin (mg/dL) | 0.1 (0.1-0.2) | 0.2 (0.1-0.2) | 0.1 (0.1-0.2) |
AST (IU/L) | 33 (24–39) | 35 (20–38) | 33 (26–45) |
ALT (IU/L) | 44 (37–67) | 40 (24–65)** | 123 (75–315)* |
ALP (IU/L) | 127 (72–218) | 335 (101–2259) | 877 (318–1113)* |
γ-GTP (IU/L) | 6.1 (3.9-7.7) | 5.1 (2.8-7.7) | 7.7 (6.0-35.8) |
Total bile acid (mg/dL) | 5.7 (2.5-23.5) | 15.8 (6.4-104.3) | 10.4 (6.2-31.2) |
Glucose (mg/dL) | 90 (81–110) | 102 (96–109) | 103 (90–375) |
NEFA (mEq/L) | 0.78 (0.64-0.97) | 0.73 (0.55-1.14) | 0.52 (0.41-0.65) |
Insulin (ng/mL) | 1.1 (0.8-1.7) | 0.7 (0.6-1.1) | 2.4 (1.2-2.5) |
Adiponectin (μg/mL) | 18.4 (15.9-30.1) | 31.9 (17.1-38.9) | 23.8 (19.0-25.9) |
Cholesterol profiles | Â | Â | Â |
HDL2,3 (mg/dl) | 191.8 (143.1-225.0) | 191.2 (167.2-240.0) | 229.7 (215.8-242.8) |
HDL1 (mg/dl) | 31.1 (24.3-85.5) | 41.7 (25.2-124.4) | 119.9 (96.3-136.6) |
VLDL/LDL (mg/dl) | 5.8 (3.3-14.4) | 22.5 (16.5-35.7)* | 21.5 (7.7-35.9) |
CM (mg/dl) | 0.0 (0.0-0.2) | 1.5 (0.0-6.7) | 0.0 (0.0-0.0) |
Triglyceride profiles | Â | Â | Â |
HDL2,3 (mg/dl) | 0.0 (0.0-0.0) | 0.0 (0.0-0.0) | 0.0 (0.0-0.2) |
HDL1 (mg/dl) | 0.5 (0.0-1.8) | 0.9 (0.75-5.0) | 3.0 (1.9-6.5)* |
VLDL/LDL (mg/dl) | 47.5 (28.1-108.4) | 193.1 (119.0-264.5)*,** | 67.9 (59.7-72.3) |
CM (mg/dl) | 0.5 (0.0-48.7) | 58.6 (0.0-119.3) | 5.6 (0.0-14.5) |